Quality control measures and effect analysis before clinical urine routine test analysis
临床尿液常规检验分析前质量控制对策与效果分析

摘要

目的 探析临床尿液常规检验分析前质量控制对策与效果。方法 本次研究对象为80份尿液样本，抽取时间为2022年6月-2023年6月期间。按照随机数字表法分为参考组及实验组，其中参考组采取常规监测，实验组在采取常规监测前采取质量控制，每组40份样本。对两组样本合理率及样本不合理情况进行对比。结果 实验组样本合理率高于参考组（P＜0.05）。结论 在临床尿液常规检验分析前阶段，合理实施质量控制措施，能显著降低不合格样本的出现率，从而提升检验的整体质量，此做法在临床上展现出极高的实用价值。

Abstract

Objective To explore the quality control measures and effects before clinical urine routine test analysis.
Methods The research subjects were 80 urine samples collected between June 2022 and June 2023. According to the random number table method, the samples were divided into a reference group and an experimental group. The reference group underwent routine monitoring, while the experimental group underwent quality control before routine monitoring. Each group had 40 samples. Compare the rationality and irrationality of two sets of samples.
Results The rationality rate of the experimental group samples was higher than that of the reference group (P<0.05).
Conclusion   Reasonable implementation of quality control measures in the pre analysis stage of clinical urine routine test can significantly reduce the occurrence rate of unqualified samples, thereby improving the overall quality of the test. This approach has shown great practical value in clinical practice.